On February 11, 2026, Envoy Medical, Inc. started a public offering to sell 47,946,150 shares of Class A Common Stock and various warrants, aiming to raise around $30 million, with insiders contributing approximately $8.4 million. The offering was finalized on February 12, 2026, and proceeds will support FDA clinical studies for their Acclaim CI device.